 | • レポートコード：GIR201106547 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ペメトレキセド薬の世界市場を調査対象にし、ペメトレキセド薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（100mg凍結乾燥粉末/バイアル、500mg凍結乾燥粉末/バイアル）、用途別分析（胸膜中皮腫、非小細胞肺がん）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Eli Lilly and Company、Eagle Pharmaceuticals、Pfizer、Biocon、Teva、Qilu Pharmaceutical、APOTEX ・メーカー別販売量、売上、市場シェア ・ペメトレキセド薬の地域別市場分析 ・ペメトレキセド薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ペメトレキセド薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ペメトレキセド薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ペメトレキセド薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ペメトレキセド薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ペメトレキセド薬の種類別市場規模2015-2020：100mg凍結乾燥粉末/バイアル、500mg凍結乾燥粉末/バイアル ・ペメトレキセド薬の用途別市場規模2015-2020：胸膜中皮腫、非小細胞肺がん ・ペメトレキセド薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Pemetrexed Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Pemetrexed Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Pemetrexed Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Pemetrexed Drug market has been segmented into
100 mg lyophilized powder/vial
500 mg lyophilized powder/vial
By Application, Pemetrexed Drug has been segmented into:
Pleural mesothelioma
Non-small cell lung cancer
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pemetrexed Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Pemetrexed Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pemetrexed Drug market.
The report offers in-depth assessment of the growth and other aspects of the Pemetrexed Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Pemetrexed Drug Market Share Analysis
Pemetrexed Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pemetrexed Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pemetrexed Drug sales, revenue and market share for each player covered in this report.
The major players covered in Pemetrexed Drug are:
Eli Lilly and Company
Eagle Pharmaceuticals
Pfizer
Biocon
Teva
Qilu Pharmaceutical
APOTEX
Among other players domestic and global, Pemetrexed Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pemetrexed Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pemetrexed Drug, with price, sales, revenue and global market share of Pemetrexed Drug in 2018 and 2019.
Chapter 3, the Pemetrexed Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pemetrexed Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Pemetrexed Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Pemetrexed Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Pemetrexed Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pemetrexed Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 100 mg lyophilized powder/vial
1.2.3 500 mg lyophilized powder/vial
1.3 Market Analysis by Application
1.3.1 Overview: Global Pemetrexed Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pleural mesothelioma
1.3.3 Non-small cell lung cancer
1.4 Overview of Global Pemetrexed Drug Market
1.4.1 Global Pemetrexed Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly and Company
2.1.1 Eli Lilly and Company Details
2.1.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eli Lilly and Company SWOT Analysis
2.1.4 Eli Lilly and Company Product and Services
2.1.5 Eli Lilly and Company Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eagle Pharmaceuticals
2.2.1 Eagle Pharmaceuticals Details
2.2.2 Eagle Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Eagle Pharmaceuticals SWOT Analysis
2.2.4 Eagle Pharmaceuticals Product and Services
2.2.5 Eagle Pharmaceuticals Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Biocon
2.4.1 Biocon Details
2.4.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Biocon SWOT Analysis
2.4.4 Biocon Product and Services
2.4.5 Biocon Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Teva
2.5.1 Teva Details
2.5.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Teva SWOT Analysis
2.5.4 Teva Product and Services
2.5.5 Teva Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Qilu Pharmaceutical
2.6.1 Qilu Pharmaceutical Details
2.6.2 Qilu Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Qilu Pharmaceutical SWOT Analysis
2.6.4 Qilu Pharmaceutical Product and Services
2.6.5 Qilu Pharmaceutical Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 APOTEX
2.7.1 APOTEX Details
2.7.2 APOTEX Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 APOTEX SWOT Analysis
2.7.4 APOTEX Product and Services
2.7.5 APOTEX Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Pemetrexed Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Pemetrexed Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Pemetrexed Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Pemetrexed Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Pemetrexed Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Pemetrexed Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Pemetrexed Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Pemetrexed Drug Sales and Growth Rate (2015-2020)
4.3 Europe Pemetrexed Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Pemetrexed Drug Sales and Growth Rate (2015-2020)
4.5 South America Pemetrexed Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Pemetrexed Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Pemetrexed Drug Sales, Revenue and Market Share by Country
5.1.1 North America Pemetrexed Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Pemetrexed Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Pemetrexed Drug Sales and Growth Rate (2015-2020)
5.3 Canada Pemetrexed Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Pemetrexed Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Pemetrexed Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Pemetrexed Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Pemetrexed Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Pemetrexed Drug Sales and Growth Rate (2015-2020)
6.3 UK Pemetrexed Drug Sales and Growth Rate (2015-2020)
6.4 France Pemetrexed Drug Sales and Growth Rate (2015-2020)
6.5 Russia Pemetrexed Drug Sales and Growth Rate (2015-2020)
6.6 Italy Pemetrexed Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Pemetrexed Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Pemetrexed Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Pemetrexed Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Pemetrexed Drug Sales and Growth Rate (2015-2020)
7.3 Japan Pemetrexed Drug Sales and Growth Rate (2015-2020)
7.4 Korea Pemetrexed Drug Sales and Growth Rate (2015-2020)
7.5 India Pemetrexed Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Pemetrexed Drug Sales and Growth Rate (2015-2020)
7.7 Australia Pemetrexed Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Pemetrexed Drug Sales, Revenue and Market Share by Country
8.1.1 South America Pemetrexed Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Pemetrexed Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Pemetrexed Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Pemetrexed Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Pemetrexed Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Pemetrexed Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Pemetrexed Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Pemetrexed Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Pemetrexed Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Pemetrexed Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Pemetrexed Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Pemetrexed Drug Sales and Market Share by Type (2015-2020)
10.2 Global Pemetrexed Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Pemetrexed Drug Price by Type (2015-2020)
11 Global Pemetrexed Drug Market Segment by Application
11.1 Global Pemetrexed Drug Sales Market Share by Application (2015-2020)
11.2 Global Pemetrexed Drug Revenue Market Share by Application (2015-2020)
11.3 Global Pemetrexed Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Pemetrexed Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Pemetrexed Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Pemetrexed Drug Market Forecast (2021-2025)
12.2.2 Europe Pemetrexed Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Pemetrexed Drug Market Forecast (2021-2025)
12.2.4 South America Pemetrexed Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Pemetrexed Drug Market Forecast (2021-2025)
12.3 Pemetrexed Drug Market Forecast by Type (2021-2025)
12.3.1 Global Pemetrexed Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Pemetrexed Drug Market Share Forecast by Type (2021-2025)
12.4 Pemetrexed Drug Market Forecast by Application (2021-2025)
12.4.1 Global Pemetrexed Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Pemetrexed Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Pemetrexed Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pemetrexed Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pemetrexed Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly and Company Pemetrexed Drug Major Business
Table 9. Eli Lilly and Company Pemetrexed Drug Total Revenue (USD Million) (2018-2019)
Table 10. Eli Lilly and Company SWOT Analysis
Table 11. Eli Lilly and Company Pemetrexed Drug Product and Services
Table 12. Eli Lilly and Company Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Eagle Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Eagle Pharmaceuticals Pemetrexed Drug Major Business
Table 15. Eagle Pharmaceuticals Pemetrexed Drug Total Revenue (USD Million) (2018-2019)
Table 16. Eagle Pharmaceuticals SWOT Analysis
Table 17. Eagle Pharmaceuticals Pemetrexed Drug Product and Services
Table 18. Eagle Pharmaceuticals Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Pemetrexed Drug Major Business
Table 21. Pfizer Pemetrexed Drug Total Revenue (USD Million) (2018-2019)
Table 22. Pfizer SWOT Analysis
Table 23. Pfizer Pemetrexed Drug Product and Services
Table 24. Pfizer Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Biocon Basic Information, Manufacturing Base and Competitors
Table 26. Biocon Pemetrexed Drug Major Business
Table 27. Biocon Pemetrexed Drug Total Revenue (USD Million) (2018-2019)
Table 28. Biocon SWOT Analysis
Table 29. Biocon Pemetrexed Drug Product and Services
Table 30. Biocon Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Teva Basic Information, Manufacturing Base and Competitors
Table 32. Teva Pemetrexed Drug Major Business
Table 33. Teva Pemetrexed Drug Total Revenue (USD Million) (2018-2019)
Table 34. Teva SWOT Analysis
Table 35. Teva Pemetrexed Drug Product and Services
Table 36. Teva Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 38. Qilu Pharmaceutical Pemetrexed Drug Major Business
Table 39. Qilu Pharmaceutical Pemetrexed Drug Total Revenue (USD Million) (2018-2019)
Table 40. Qilu Pharmaceutical SWOT Analysis
Table 41. Qilu Pharmaceutical Pemetrexed Drug Product and Services
Table 42. Qilu Pharmaceutical Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. APOTEX Basic Information, Manufacturing Base and Competitors
Table 44. APOTEX Pemetrexed Drug Major Business
Table 45. APOTEX Pemetrexed Drug Total Revenue (USD Million) (2018-2019)
Table 46. APOTEX SWOT Analysis
Table 47. APOTEX Pemetrexed Drug Product and Services
Table 48. APOTEX Pemetrexed Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Pemetrexed Drug Sales by Manufacturer (2018-2019) (K Units)
Table 50. Global Pemetrexed Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Pemetrexed Drug Sales by Regions (2015-2020) (K Units)
Table 52. Global Pemetrexed Drug Sales Market Share by Regions (2015-2020)
Table 53. Global Pemetrexed Drug Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Pemetrexed Drug Sales by Countries (2015-2020) (K Units)
Table 55. North America Pemetrexed Drug Sales Market Share by Countries (2015-2020)
Table 56. North America Pemetrexed Drug Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Pemetrexed Drug Revenue Market Share by Countries (2015-2020)
Table 58. Europe Pemetrexed Drug Sales by Countries (2015-2020) (K Units)
Table 59. Europe Pemetrexed Drug Sales Market Share by Countries (2015-2020)
Table 60. Europe Pemetrexed Drug Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Pemetrexed Drug Sales by Regions (2015-2020) (K Units)
Table 62. Asia-Pacific Pemetrexed Drug Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Pemetrexed Drug Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Pemetrexed Drug Sales by Countries (2015-2020) (K Units)
Table 65. South America Pemetrexed Drug Sales Market Share by Countries (2015-2020)
Table 66. South America Pemetrexed Drug Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Pemetrexed Drug Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Pemetrexed Drug Sales by Countries (2015-2020) (K Units)
Table 69. Middle East & Africa Pemetrexed Drug Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Pemetrexed Drug Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Pemetrexed Drug Revenue Market Share by Countries (2015-2020)
Table 72. Global Pemetrexed Drug Sales by Type (2015-2020) (K Units)
Table 73. Global Pemetrexed Drug Sales Share by Type (2015-2020)
Table 74. Global Pemetrexed Drug Revenue by Type (2015-2020) (USD Million)
Table 75. Global Pemetrexed Drug Revenue Share by Type (2015-2020)
Table 76. Global Pemetrexed Drug Sales by Application (2015-2020) (K Units)
Table 77. Global Pemetrexed Drug Sales Share by Application (2015-2020)
Table 78. Global Pemetrexed Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 79. Global Pemetrexed Drug Market Share Forecast by Regions (2021-2025)
Table 80. Global Pemetrexed Drug Sales Forecast by Type (2021-2025) (K Units)
Table 81. Global Pemetrexed Drug Market Share Forecast by Type (2021-2025)
Table 82. Global Pemetrexed Drug Sales Forecast by Application (2021-2025)
Table 83. Global Pemetrexed Drug Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Pemetrexed Drug Picture
Figure 2. Global Sales Market Share of Pemetrexed Drug by Type in 2019
Figure 3. 100 mg lyophilized powder/vial Picture
Figure 4. 500 mg lyophilized powder/vial Picture
Figure 5. Pemetrexed Drug Sales Market Share by Application in 2018
Figure 6. Pleural mesothelioma Picture
Figure 7. Non-small cell lung cancer Picture
Figure 8. Global Pemetrexed Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Pemetrexed Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Pemetrexed Drug Sales Market Share by Manufacturer in 2019
Figure 29. Global Pemetrexed Drug Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Pemetrexed Drug Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Pemetrexed Drug Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Pemetrexed Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Pemetrexed Drug Revenue Market Share by Regions (2015-2020)
Figure 36. Global Pemetrexed Drug Revenue Market Share by Regions in 2018
Figure 37. North America Pemetrexed Drug Sales and Growth Rate (2015-2020)
Figure 38. Europe Pemetrexed Drug Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Pemetrexed Drug Sales and Growth Rate (2015-2020)
Figure 40. South America Pemetrexed Drug Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Pemetrexed Drug Sales and Growth Rate (2015-2020)
Figure 42. North America Pemetrexed Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Pemetrexed Drug Sales Market Share by Countries (2015-2020)
Figure 44. North America Pemetrexed Drug Sales Market Share by Countries in 2018
Figure 45. North America Pemetrexed Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Pemetrexed Drug Revenue Market Share by Countries in 2018
Figure 47. United States Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Pemetrexed Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Pemetrexed Drug Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Pemetrexed Drug Revenue Market Share by Countries in 2019
Figure 53. Germany Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Pemetrexed Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Pemetrexed Drug Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Pemetrexed Drug Revenue Market Share by Regions 2019
Figure 61. China Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Pemetrexed Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Pemetrexed Drug Sales Market Share by Countries in 2019
Figure 68. South America Pemetrexed Drug Revenue Market Share by Countries in 2019
Figure 69. Brazil Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Pemetrexed Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Pemetrexed Drug Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Pemetrexed Drug Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Pemetrexed Drug Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Pemetrexed Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Pemetrexed Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Pemetrexed Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Pemetrexed Drug Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Pemetrexed Drug Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Pemetrexed Drug Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Pemetrexed Drug Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Pemetrexed Drug Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
スニチニブ薬の世界市場 2020年 Market Overview The global Sunitinib Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sunitinib Drug market report p…- 基底細胞母斑症候群治療薬の世界市場 2020年 Market Overview The global Basal Cell Nevus Syndrome Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Basal Cell Nev…
- 未分化甲状腺がん治療薬の世界市場 2020年 Market Overview The global Anaplastic Thyroid Cancer Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anaplastic Thy…
- CDK 4及び6阻害薬の世界市場 2020年 Market Overview The CDK 4 and 6 Inhibitor Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 抗体薬物複合体の世界市場 2020年 Market Overview The Antibody-drug Conjugates market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…